GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Shiller PE Ratio

Intelgenx Technologies (FRA:0IL) Shiller PE Ratio : (As of Jun. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Intelgenx Technologies Shiller PE Ratio Historical Data

The historical data trend for Intelgenx Technologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies Shiller PE Ratio Chart

Intelgenx Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Intelgenx Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Intelgenx Technologies's Shiller PE Ratio

For the Biotechnology subindustry, Intelgenx Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelgenx Technologies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Intelgenx Technologies's Shiller PE Ratio falls into.



Intelgenx Technologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Intelgenx Technologies's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Intelgenx Technologies's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.018/126.2576*126.2576
=-0.018

Current CPI (Mar. 2024) = 126.2576.

Intelgenx Technologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.007 99.473 -0.009
201409 -0.008 99.394 -0.010
201412 0.000 98.367 0.000
201503 -0.001 99.789 -0.001
201506 -0.004 100.500 -0.005
201509 0.018 100.421 0.023
201512 0.000 99.947 0.000
201603 -0.009 101.054 -0.011
201606 -0.009 102.002 -0.011
201609 0.000 101.765 0.000
201612 0.000 101.449 0.000
201703 -0.009 102.634 -0.011
201706 -0.009 103.029 -0.011
201709 -0.008 103.345 -0.010
201712 -0.017 103.345 -0.021
201803 -0.024 105.004 -0.029
201806 -0.034 105.557 -0.041
201809 -0.034 105.636 -0.041
201812 -0.026 105.399 -0.031
201903 -0.027 106.979 -0.032
201906 -0.027 107.690 -0.032
201909 -0.027 107.611 -0.032
201912 -0.027 107.769 -0.032
202003 -0.027 107.927 -0.032
202006 -0.009 108.401 -0.010
202009 -0.008 108.164 -0.009
202012 -0.016 108.559 -0.019
202103 -0.017 110.298 -0.019
202106 -0.017 111.720 -0.019
202109 -0.009 112.905 -0.010
202112 -0.018 113.774 -0.020
202203 -0.018 117.646 -0.019
202206 -0.019 120.806 -0.020
202209 -0.020 120.648 -0.021
202212 -0.009 120.964 -0.009
202303 -0.019 122.702 -0.020
202306 -0.018 124.203 -0.018
202309 -0.009 125.230 -0.009
202312 -0.009 125.072 -0.009
202403 -0.018 126.258 -0.018

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Intelgenx Technologies  (FRA:0IL) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Intelgenx Technologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelgenx Technologies (FRA:0IL) Business Description

Traded in Other Exchanges
Address
6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Intelgenx Technologies (FRA:0IL) Headlines

No Headlines